SB203580, a pharmacological inhibitor of p38 MAP kinase transduction pathway activates ERK and JNK MAP kinases in primary cultures of human hepatocytes

Abstract

SB203580, a pharmacological inhibitor of p38 MAP kinase transduction pathway activates ERK and JNK MAP kinases in primary cultures of human hepatocytes

Keywords

• human hepatocyte
• p38 MAPK kinase
• extracellular-regulated kinase ERK
• c-Jun-N-terminal kinase
• SB203580
• cross-talk